Bristol-Myers Squibb gets rated a hold, as I see future value in its clinical portfolio and pipeline, particularly ...
A professor says that Indonesia needs to follow up on India's success in facilitating affordable prices for medicines and medical devices for public.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback